Humana Share Price (NYSE: HUM)

$298.82

▲

1.62

(0.55%)

Last updated on August 27, 2025 at 1:29 AM IST

$₹

Check the interactive Humana Stock chart to analyse performance

Humana stock performance

as on August 27, 2025 at 1:29 AM IST

Today's Low:$296.46
Today's High:$300.61
$298.82
0.79%
Downside
Day's Volatility :1.38%
Upside
0.6%
52 Weeks Low:$206.87
52 Weeks High:$382.72
$298.82
30.77%
Downside
52 Weeks Volatility :45.95%
Upside
21.92%

Humana Stock Returns

Period	Humana Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	30.48%	4.5%	0.0%
6 Months	16.52%	-7.9%	0.0%
1 Year	-15.91%	-12.3%	0.0%
3 Years	-39.12%	7.0%	-6.9%

Humana Inc. Key Stats

Check Humana key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$297.2
Open	$297.25
Today's High	$300.61
Today's Low	$296.46
Market Capitalization	$35.7B
Today's Volume	$880.1K
52 Week High	$382.72
52 Week Low	$206.87
Revenue TTM	$123.1B
EBITDA	$4.0B
Earnings Per Share (EPS)	$13.06
PE Ratio	22.76
Dividend Yield	1.18%
Profit Margin	1.28%
Quarterly Earnings Growth YOY	-0.2%
Return On Equity TTM	9.03%

Stock Returns calculator for Humana Stock including INR - Dollar returns

The Humana stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Humana investment value today

Current value as on today

₹89,071

Returns

₹10,929

(-10.93%)

Returns from Humana Stock

₹15,456 (-15.46%)

Dollar Returns*

₹4,527 (+4.53%)

Indian investors sentiment towards Humana Stock

-13%

Period: Jul 27, 2025 to Aug 26, 2025. Change in 30 Days versus previous period

Search interest for Humana Stock from India on INDmoney has decreased by -13% in the last 30 days, reflecting a downward trend in search activity.

Indian Mutual Funds that invest in Humana Stock

Name	Shares Held	Change in Shares	% of Assets
Motilal Oswal S&P 500 Index Fund Direct Growth	976	0.24	0.06%

Global Institutional Holdings in Humana Inc.

Name
Holdings %
Name
Holdings %
Vanguard Group Inc
11.81%
Dodge & Cox
9.44%
BlackRock Inc
9.19%
State Street Corp
4.42%
Eagle Capital Management LLC
3.28%
Pzena Investment Management, LLC
3.18%

Analyst Recommendation on Humana Stock

Rating

Trend

Buy

51%Buy

48%Hold

0%Sell

Based on 27 Wall street analysts offering stock ratings for Humana(by analysts ranked 0 to 5 stars)

Humana Share Price Target

What analysts predicted

Downside of 2.34%

Target:

$291.82

Current:

$298.82

Humana share price target is $291.82, a slight Downside of 2.34% compared to current price of $298.82 as per analysts' prediction.

Humana Stock Insights

Price Movement
In the last 1 month, HUM stock has moved up by 24.9%
Increasing Revenue
Humana Inc. has shown positive revenue growth over the last three quarters. The revenue increased from $29.21 billion to $32.38 billion, with an average growth of 4.9% per quarter.
Decreasing Net Profit
Humana Inc. has experienced a decline in net profit over the last two quarters. The profit decreased from $1.24 billion to $545 million, showing an average decrease of 56.2% per quarter.
HUM vs CVS (1 yr)
In the last 1 year, Cvs Health Corporation has given 21.3% return, outperforming this stock by 37.1%
HUM vs CI (3 yr)
In the last 3 years, Humana Inc. has experienced a drawdown of -38.9%, however The Cigna Corp resisted the overall trend and outperformed by 10.1%
Price to Sales
Humana Inc. has a Price-to-Sales Ratio of $0.3, meaning that investors are willing to pay $0.3 for every $1 of sales the company generates. In comparison, investors pay $0.2 for every $1 of sales for CVS Health Corporation. This suggests that Humana Inc. is perceived as more valuable by investors relative to its sales compared to CVS Health Corporation.

Humana Inc. Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$64.9B	↑ 14.01%
Net Income	$2.7B	↑ 60.84%
Net Profit Margin	4.17%	↑ 1.21%

	FY20	Y/Y Change
Revenue	$77.2B	↑ 18.9%
Net Income	$3.4B	↑ 24.38%
Net Profit Margin	4.36%	↑ 0.19%

	FY21	Y/Y Change
Revenue	$83.1B	↑ 7.66%
Net Income	$2.9B	↓ 12.89%
Net Profit Margin	3.53%	↓ 0.83%

	FY22	Y/Y Change
Revenue	$92.9B	↑ 11.81%
Net Income	$2.8B	↓ 4.33%
Net Profit Margin	3.02%	↓ 0.51%

	FY23	Y/Y Change
Revenue	$106.4B	↑ 14.54%
Net Income	$2.5B	↓ 11.3%
Net Profit Margin	2.34%	↓ 0.68%

	FY24	Y/Y Change
Revenue	$117.8B	↑ 10.7%
Net Income	$1.2B	↓ 51.51%
Net Profit Margin	1.02%	↓ 1.32%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$29.6B	↑ 11.9%
Net Income	$741.0M	↓ 236.97%
Net Profit Margin	2.5%	↑ 4.54%

	Q2 FY24	Q/Q Change
Revenue	$29.5B	↓ 0.24%
Net Income	$679.0M	↓ 8.37%
Net Profit Margin	2.3%	↓ 0.2%

	Q3 FY24	Q/Q Change
Revenue	$29.4B	↓ 0.48%
Net Income	$480.0M	↓ 29.31%
Net Profit Margin	1.63%	↓ 0.67%

	Q4 FY24	Q/Q Change
Revenue	$29.2B	↓ 0.63%
Net Income	$-693.0M	↓ 244.37%
Net Profit Margin	-2.37%	↓ 4.0%

	Q1 FY25	Q/Q Change
Revenue	$32.1B	↑ 9.92%
Net Income	$1.2B	↓ 279.51%
Net Profit Margin	3.87%	↑ 6.24%

	Q2 FY25	Q/Q Change
Revenue	$32.4B	↑ 0.86%
Net Income	$545.0M	↓ 56.19%
Net Profit Margin	1.68%	↓ 2.19%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$64.9B	↑ 14.01%

	FY20	Y/Y Change
Profit	$77.2B	↑ 18.9%

	FY21	Y/Y Change
Profit	$83.1B	↑ 7.66%

	FY22	Y/Y Change
Profit	$92.9B	↑ 11.81%

	FY23	Y/Y Change
Profit	$106.4B	↑ 14.54%

	FY24	Y/Y Change
Profit	$117.8B	↑ 10.7%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$29.6B	↑ 11.9%

	Q2 FY24	Q/Q Change
Profit	$29.5B	↓ 0.24%

	Q3 FY24	Q/Q Change
Profit	$29.4B	↓ 0.48%

	Q4 FY24	Q/Q Change
Profit	$29.2B	↓ 0.63%

	Q1 FY25	Q/Q Change
Profit	$32.1B	↑ 9.92%

	Q2 FY25	Q/Q Change
Profit	$32.4B	↑ 0.86%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$5.3B	↑ 143.17%
Investing Cash Flow	$-1.3B	↓ 58.6%
Financing Cash Flow	$-2.3B	↑ 192.36%

	FY20	Y/Y Change
Operating Cash Flow	$5.6B	↑ 6.72%
Investing Cash Flow	$-3.1B	↑ 139.83%
Financing Cash Flow	$-2.0B	↓ 14.81%

	FY21	Y/Y Change
Operating Cash Flow	$2.3B	↓ 59.89%
Investing Cash Flow	$-6.6B	↑ 113.9%
Financing Cash Flow	$3.0B	↓ 254.22%

	FY22	Y/Y Change
Operating Cash Flow	$4.6B	↑ 102.79%
Investing Cash Flow	$-1.0B	↓ 84.66%
Financing Cash Flow	$-1.9B	↓ 163.48%

	FY23	Y/Y Change
Operating Cash Flow	$4.0B	↓ 13.21%
Investing Cash Flow	$-3.5B	↑ 247.12%
Financing Cash Flow	$-856.0M	↓ 55.28%

	FY24	Y/Y Change
Operating Cash Flow	$3.0B	↓ 25.5%
Investing Cash Flow	$-3.0B	↓ 15.46%
Financing Cash Flow	$-2.5B	↑ 190.54%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$423.0M	↓ 105.93%
Investing Cash Flow	$-414.0M	↓ 53.06%
Financing Cash Flow	$1.2B	↓ 149.51%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$1.2B	↑ 186.76%
Investing Cash Flow	$-1.0B	↑ 142.03%
Financing Cash Flow	$-620.0M	↓ 151.37%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$1.9B	↑ 53.17%
Investing Cash Flow	$-1.5B	↑ 47.01%
Financing Cash Flow	$-770.0M	↑ 24.19%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-528.0M	↓ 128.42%
Investing Cash Flow	$-63.0M	↓ 95.72%
Financing Cash Flow	$-2.3B	↑ 199.22%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$331.0M	↓ 162.69%
Investing Cash Flow	$314.0M	↓ 598.41%
Financing Cash Flow	$1.4B	↓ 160.07%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$1.3B	↑ 283.99%
Investing Cash Flow	$347.0M	↑ 10.51%
Financing Cash Flow	$-1.8B	↓ 232.08%

Humana Technicals Summary

Sell

Neutral

Buy

Humana is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Humana Inc. Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Humana Inc.	28.38%	16.52%	-15.91%	-39.12%	-27.16%
The Cigna Corp	2.81%	-1.55%	-15.06%	4.67%	65.94%
Cvs Health Corporation	19.41%	11.52%	23.94%	-29.02%	12.66%
Elevance Health, Inc	9.94%	-18.57%	-42.67%	-35.64%	13.39%
Unitedhealth Group Incorporated	8.11%	-34.21%	-48.07%	-42.43%	-2.98%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Humana Inc.	22.76	22.76	1.02	16.93	0.09	0.05	0.01	151.61
The Cigna Corp	16.7	16.7	0.6	29.66	0.13	0.04	0.02	150.84
Cvs Health Corporation	19.86	19.86	0.74	6.3	0.06	0.02	0.04	61.07
Elevance Health, Inc	13.42	13.42	0.85	30.02	0.12	0.05	0.02	194.46
Unitedhealth Group Incorporated	13.31	13.31	1.25	16.23	0.22	0.06	0.03	104.67

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Humana Inc.	Buy	$35.7B	-27.16%	22.76	1.28%
The Cigna Corp	Buy	$81.2B	65.94%	16.7	1.92%
Cvs Health Corporation	Buy	$90.4B	12.66%	19.86	1.18%
Elevance Health, Inc	Buy	$71.3B	13.39%	13.42	2.83%
Unitedhealth Group Incorporated	Buy	$278.4B	-2.98%	13.31	5.04%

Humana Dividend announcements

Humana Dividends September, 2025
In the quarter ending September,2025. Humana has declared dividend of $0.89

About Humana Inc.

Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. It offers medical care and supplemental benefit plans to individuals. The company also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, it provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; and military services, such as TRICARE T2017 East Region contract. Further, the company engages in the operation of pharmacy benefit manager business; operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. It sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Organization	Humana
Employees	65680
CEO	Mr. James A. Rechtin M.B.A.
Industry	Health Services

Key Management of Humana Inc.

Name	Title
Mr. James A. Rechtin M.B.A.	President, CEO & Director
Mr. Bruce Dale Broussard	Strategic Advisor
Mr. George Renaudin II	President of Insurance
Dr. Sanjay K. Shetty M.B.A., M.D.	President of CenterWell
Mr. David E. Dintenfass	President of Enterprise Growth
Ms. Celeste Marie Mellet	Chief Financial Officer
Mr. John-Paul William Felter	Senior VP, Chief Accounting Officer & Controller
Mr. Japan A. Mehta	Chief Information Officer
Ms. Lisa M. Stoner	Vice President of Investor Relations
Mr. Joseph C. Ventura	Chief Legal Officer

Important FAQs about investing in HUM Stock from India :

What is Humana share price today?

Humana share price today is $298.82 as on August 27, 2025 at 1:29 AM IST at the close of the market. Humana share today touched a day high of $300.61 and a low of $296.46.

What is the 52 week high and 52 week low for Humana share?

Humana share touched a 52 week high of $382.72 and a 52 week low of $206.87. Humana stock price today i.e. August 27, 2025 at 1:29 AM IST is closed at $298.82, lower by 21.92% versus the 52 week high.

How to invest in Humana Stock (HUM) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Humana on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Humana Shares that will get you 0.0050 shares as per Humana share price of $298.82 per share as on August 27, 2025 at 1:29 AM IST.

What is the minimum amount required to buy Humana Stock (HUM) from India?

Indian investors can start investing in Humana (HUM) shares with as little as ₹87.6525 or $1 (as of August 27, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹876.53 in Humana stock (as per the Rupee-Dollar exchange rate as on August 27, 2025). Based on Humana share’s latest price of $298.82 as on August 27, 2025 at 1:29 AM IST, you will get 0.0335 shares of Humana. Learn more about fractional shares .

What are the returns that Humana has given to Indian investors in the last 5 years?

Humana stock has given -27.16% share price returns and 18.61% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?